Hepatic glucuronidation of 4-tert-octylphenol in humans: inter-individual variability and responsible UDP-glucuronosyltransferase isoforms
- PMID: 28500425
- DOI: 10.1007/s00204-017-1982-1
Hepatic glucuronidation of 4-tert-octylphenol in humans: inter-individual variability and responsible UDP-glucuronosyltransferase isoforms
Abstract
4-tert-Octylphenol (4-tOP) is an endocrine-disrupting chemical. It is mainly metabolized into glucuronide by UDP-glucuronosyltransferase (UGT) enzymes in humans. The purpose of this study was to assess inter-individual variability in and the possible roles of UGT isoforms in hepatic 4-tOP glucuronidation in the humans. 4-tOP glucuronidation activities in the liver microsomes and recombinant UGTs of humans were assessed at broad substrate concentrations, and kinetics were analyzed. Correlation analyses between 4-tOP and diclofenac or 4-hydroxybiphenyl activities in pooled and individual human liver microsomes were also performed. Typical CLint values were 17.8 mL/min/mg protein for the low type, 25.2 mL/min/mg protein for the medium type, and 47.7 mL/min/mg protein for the high type. Among the recombinant UGTs (13 isoforms) examined, UGT2B7 and UGT2B15 were the most active of catalyzing 4-tOP glucuronidation. Although the K m values of UGT2B7 and UGT2B15 were similar (0.36 and 0.42 µM, respectively), the CLint value of UGT2B7 (6.83 mL/min/mg protein) >UGT2B15 (2.35 mL/min/mg protein). Strong correlations were observed between the glucuronidation activities of 4-tOP and diclofenac (a probe for UGT2B7) or 4-hydroxybiphenyl (a probe for UGT2B15) with 0.79-0.88 of Spearman correlation coefficient (r s) values. These findings demonstrate that 4-tOP glucuronidation in humans is mainly catalyzed by hepatic UGT2B7 and UGT2B15, and suggest that these UGT isoforms play important and characteristic roles in the detoxification of 4-tOP.
Keywords: 4-tert-Octylphenol (4-tOP); Glucuronidation; Human liver microsome; Recombinant human UGT; UDP-glucuronosyltransferase (UGT).
Similar articles
-
Human UDP-glucuronosyltransferase isoforms involved in bisphenol A glucuronidation.Chemosphere. 2008 Dec;74(1):33-6. doi: 10.1016/j.chemosphere.2008.09.053. Epub 2008 Nov 5. Chemosphere. 2008. PMID: 18990428
-
Glucuronidation of mono(2-ethylhexyl) phthalate in humans: roles of hepatic and intestinal UDP-glucuronosyltransferases.Arch Toxicol. 2017 Feb;91(2):689-698. doi: 10.1007/s00204-016-1708-9. Epub 2016 Apr 12. Arch Toxicol. 2017. PMID: 27071666
-
Characterization of rat and human UDP-glucuronosyltransferases responsible for the in vitro glucuronidation of diclofenac.Toxicol Sci. 2001 May;61(1):49-53. doi: 10.1093/toxsci/61.1.49. Toxicol Sci. 2001. PMID: 11294973
-
Evidence-based strategies for the characterisation of human drug and chemical glucuronidation in vitro and UDP-glucuronosyltransferase reaction phenotyping.Pharmacol Ther. 2021 Feb;218:107689. doi: 10.1016/j.pharmthera.2020.107689. Epub 2020 Sep 25. Pharmacol Ther. 2021. PMID: 32980440 Review.
-
Species differences in drug glucuronidation: Humanized UDP-glucuronosyltransferase 1 mice and their application for predicting drug glucuronidation and drug-induced toxicity in humans.Drug Metab Pharmacokinet. 2018 Feb;33(1):9-16. doi: 10.1016/j.dmpk.2017.10.002. Epub 2017 Oct 7. Drug Metab Pharmacokinet. 2018. PMID: 29079228 Free PMC article. Review.
Cited by
-
Sulfonation and glucuronidation of hydroxylated bromodiphenyl ethers in human liver.Chemosphere. 2019 Jul;226:132-139. doi: 10.1016/j.chemosphere.2019.03.103. Epub 2019 Mar 20. Chemosphere. 2019. PMID: 30925405 Free PMC article.
-
Integrated Metabolomics and Transcriptomics Analyses Reveal Metabolic Changes in Primary Angiitis of the Central Nervous System.J Inflamm Res. 2025 Feb 25;18:2767-2780. doi: 10.2147/JIR.S503058. eCollection 2025. J Inflamm Res. 2025. PMID: 40026305 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources